Northland Capital Markets Upgrades Impax Laboratories (IPXL) to Outperform
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Northland Capital Markets upgraded Impax Laboratories (NASDAQ: IPXL) from Market Perform to Outperform with a price target of $30.00.
Shares of Impax Laboratories closed at $21.72 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: UBS Upgrades Swift Transportation (SWFT) to Buy
- Wedbush Upgrades Time Warner (TWX) to Outperform; Expects the Deal to Go Through
- Jefferies Raises Price Target on Rambus (RMBS) Following 3Q Report
Create E-mail Alert Related CategoriesUpgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!